tiprankstipranks
Trending News
More News >
Crescent Biopharma (CBIO)
NASDAQ:CBIO
US Market

Crescent Biopharma (CBIO) Income Statement

Compare
995 Followers

Crescent Biopharma Income Statement

Last quarter (Q3 2025), Crescent Biopharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Crescent Biopharma's net income was $-24.61M. See Crescent Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 10.00K$ 75.00K$ 1.16M$ 10.16M
Gross Profit
$ 0.00$ 10.00K$ 75.00K$ 1.16M$ 10.16M
Operating Expenses
$ 68.76M$ 39.29M$ 47.48M$ 64.61M$ 61.67M
Depreciation and Amortization
$ 68.76M$ 153.30K$ 207.15K$ 264.60K$ 270.75K
EBITDA
$ 0.00$ -39.12M$ -47.20M$ -63.18M$ -51.24M
Operating Income
$ -68.76M$ -39.28M$ -47.40M$ -63.45M$ -51.51M
Other Income/Expenses
$ -2.70M$ 2.38M$ 714.96K$ 19.77K$ 482.49K
Pretax Income
$ -71.47M$ -36.90M$ -46.69M$ -63.43M$ -51.03M
Net Income
$ -71.47M$ -36.90M$ -46.69M$ -63.43M$ -51.03M
Per Share Metrics
Basic EPS
$ -0.59$ -0.58$ -0.89$ -1.23$ -1.12
Diluted EPS
$ -0.59$ -0.58$ -0.89$ -1.23$ -1.12
Weighted Average Shares Outstanding
64.48M 63.34M 52.53M 51.45M 45.72M
Weighted Average Shares Outstanding (Diluted)
64.48M 63.34M 52.53M 51.45M 45.72M
Currency in USD

Crescent Biopharma Earnings and Revenue History